News Feed

ArcPacific Resources Acquires Key Patented Claims to Expand Rickard Gold Mine Property in Timmins Ontario and Arranges Private Placement

Vancouver, British Columbia–(Newsfile Corp. – November 20, 2020) –  ArcPacific Resources Corp. (TSXV: ACP) (“ACP” or the “Company“) is pleased to announce it has entered into a purchase and sale agreement dated November 17, 2020 (the “Purchase […]

No Picture
News Feed

Arizona Silver Intersects 33.56 gpt Gold And 54.7 gpt Silver Over 2.35 Metres at Philadelphia Gold Silver Property in Mohave County, Arizona

Highlights: Highest grades of gold, silver, and beryllium encountered to date in hole PC20-37, as follows: 33.56 grams/tonne (gpt) Au and 54.7 gpt Ag over 2.35 metres, within a thicker interval of 10.76 metres containing 9.26 […]

News Feed

C-COM PARTNERS WITH INTERNATIONAL CONSORTIUM TO DEVELOP NEXT GENERATION PHASED ARRAY ANTENNAS FOR 5G AND SATELLITE NETWORKS

“We are pleased to be part of this ambitious and challenging project, which will lead to the development of the next generation 5G mmWave antenna technology for terrestrial as well as for high frequency (V-band) satellite broadband communications,“ said Dr. Leslie Klein, President & CEO of C-COM […]

No Picture
News Feed

Arizona Silver Announces a New High-Grade Gold-Silver Intercept at Philadelphia Gold Silver Property in Arizona

The first core hole of 2020 returns high grade gold-silver intercept in the target vein, as follows:

23.35 grams/tonne (gpt) Au, 82.3 gpt Ag & 340 ppm of Beryllium over 1.5 metres, within a thicker interval of 18.45 metres containing 3.81 gpt Au and 49.21 gpt Ag & 113 ppm of Beryllium […]

No Picture
News Feed

Citius Forms Scientific Advisory Board for the Planned Development of its Proprietary Treatment for Acute Respiratory Disease Associated with COVID-19

– Pulmonology opinion leaders in ARDS therapies will bring invaluable insight in Company’s clinical trial design CRANFORD, N.J., July 22, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“CITIUS”) (“Company”) (NASDAQ: CTXR), a specialty pharmaceutical company focused on developing and […]